BIOSENSOR CORP
10QSB/A, 1996-11-18
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: ARCH FUND INC, 497, 1996-11-18
Next: PAR TECHNOLOGY CORP, 10-Q/A, 1996-11-18





                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 AMENDMENT NO. 1
                                       TO
                                   FORM 10-QSB


[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 For the Quarterly period ended August 31, 1996

[ ] TRANSITION REPORT UNDER SECTION 13 or 15(d) OF THE EXCHANGE ACT For the
transition period from _____ to _____


                         COMMISSION FILE NUMBER 0-11408
                              BIOSENSOR CORPORATION
 ------------------------------------------------------------------------------

            MINNESOTA                                   41-1427114
  (State or other jurisdiction             (I.R.S. Employer Identification No.)
of incorporation or organization)


      13755 First Avenue North,
         Plymouth, Minnesota                               55441
(Address of principal executive offices)                 (Zip Code)


Issuer's telephone number  (612) 449-9100


Check whether the Issuer: (1) filed all reports required to be filed by Section
13 or 15(d) of the Exchange Act during the 12 months (or for such shorter period
that registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.
YES __X__    NO ____

The number of shares outstanding of the registrant's common stock, $.05 par
value, as of October 10, 1996 is 2,823,055.

This 10-QSB/A is being submitted to include the Financial Data Schedule omitted
from the initial filing.



                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the Registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


BIOSENSOR CORPORATION



B. Steven Springrose
President and Chief Executive Officer

Date  October ___, 1996


<TABLE> <S> <C>


<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          MAY-31-1997
<PERIOD-START>                             JUN-01-1996
<PERIOD-END>                               AUG-31-1996
<CASH>                                             135
<SECURITIES>                                         0
<RECEIVABLES>                                      503
<ALLOWANCES>                                         0
<INVENTORY>                                        380
<CURRENT-ASSETS>                                  1046
<PP&E>                                              68
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    1123
<CURRENT-LIABILITIES>                              597
<BONDS>                                              0
                                0
                                          0
<COMMON>                                           141
<OTHER-SE>                                         385
<TOTAL-LIABILITY-AND-EQUITY>                      1123
<SALES>                                            550
<TOTAL-REVENUES>                                   550
<CGS>                                              241
<TOTAL-COSTS>                                      241
<OTHER-EXPENSES>                                   304
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  (318)
<INCOME-TAX>                                         1
<INCOME-CONTINUING>                              (319)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (319)
<EPS-PRIMARY>                                    (.11)
<EPS-DILUTED>                                    (.11)
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission